Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 15, 2015 08:50 ET | Source: Amyris, Inc.

Amyris Announces Pricing of Its $57.6 Million of Convertible Senior Notes Due 2019 With a Conversion Price of $2.25 Per Share

EMERYVILLE, Calif., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has priced its previously announced private offering of...
October 14, 2015 09:13 ET | Source: Amyris, Inc.

Amyris Announces Offering of $50 Million of Convertible Senior Notes Due 2019

EMERYVILLE, Calif., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the offering, subject to market conditions, of $50 million of...
October 12, 2015 08:30 ET | Source: Amyris, Inc.

Amyris Achieves Record Low Cost Farnesene Production

EMERYVILLE, Calif., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that after achieving a record low manufacturing cost of $1.75 per...
October 06, 2015 08:30 ET | Source: Amyris, Inc.

Third Unique Fermentation Product Successfully Produced at Amyris Industrial Plant in Brasil

EMERYVILLE, Calif., Oct. 6, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the manufacturing of its third product produced this year at its...
September 23, 2015 08:30 ET | Source: Amyris, Inc.

Amyris Announces Multi-Year Technology Investment Agreement With DARPA Worth Up to $35 Million

EMERYVILLE, Calif., Sept. 23, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced a multi-year, Technology Investment Agreement (TIA) worth up to...
September 11, 2015 08:30 ET | Source: Amyris, Inc.

Amyris to Enter Into Exclusive Cosmetic Distribution Partnership With Leading Brazil Cosmetic Retailer

EMERYVILLE, Calif., Sept. 11, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has entered into a Memorandum of Understanding for an...
September 09, 2015 08:30 ET | Source: Amyris, Inc.

Amyris and IDRI Announce Agreement to Explore Testing and Development of Amyris Materials for Use in Vaccine Adjuvant Formulations

EMERYVILLE, Calif. and SEATTLE, Sept. 9, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and IDRI (Infectious Disease Research Institute), a Seattle-based...
September 02, 2015 12:50 ET | Source: Amyris, Inc.

Amyris to Present at Rodman & Renshaw 17th Annual Global Investment Conference on September 9, 2015

EMERYVILLE, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that management will be presenting at the Rodman & Renshaw 17th...
September 02, 2015 08:30 ET | Source: Amyris, Inc.

Amyris Set to Increase Global Growth of Its Cosmetic Emollients Through ISO 22716 Certification

EMERYVILLE, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that in support of customer requirements for increasing sales to...
August 31, 2015 08:30 ET | Source: Amyris, Inc.

Amyris Achieves Breakthrough Performance With 2nd Fragrance Molecule Ready for Industrial Scale Fermentation in Less Than 12 Months

EMERYVILLE, Calif., Aug. 31, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, announced today that it has developed a yeast strain ready to produce a new...